Showing results (1721-1730 of 22,533) with videos related to
Sort By:
Pageof 2,254
Emerging Infectious Diseases|August 2, 2003
Antimicrobial resistance markers of class 1 and class 2 integron-bearing Escherichia coli from irrigation water and sedimentsMatthew T Roe, Everardo Vega, Suresh D PillaiBiochemical Pharmacology|December 31, 2003
Statins upregulate CD36 expression in human monocytes, an effect strengthened when combined with PPAR-gamma ligands Putative contribution of Rho GTPases in statin-induced CD36 expressionNatividad Ruiz-Velasco, Angeles Domínguez, Miguel A VegaRevista Latinoamericana De Microbiologia|January 1, 1992
[Presence of antibodies against Toxoplasma gondii in adolescents from the African continent]R López, R Contreras, L Font, et al.Infection and Immunity|July 1, 1992
Effects of staphylococcal enterotoxin B on rodent mast cellsJ Komisar, J Rivera, A Vega, et al.Journal of Magnetic Resonance (San Diego, Calif. : 1997)|July 21, 2004
High resolution heteronuclear correlation NMR spectroscopy between quadrupolar nuclei and protons in the solid stateA Goldbourt, E Vinogradov, G Goobes, et al.Journal of Neuroimmunology|May 1, 1995
Distribution of neurotrophin receptors in human palatine tonsils: an immunohistochemical studyJ Hannestad, M B Levanti, J A VegaScientific Reports|July 27, 2019
Evaluating link prediction by diffusion processes in dynamic networksDidier A Vega-Oliveros, Liang Zhao, Lilian BertonCells|September 11, 2019
Assessing the Epigenetic Status of Human TelomeresMaría I Vaquero-Sedas, Miguel A Vega-PalasPhysical Chemistry Chemical Physics : PCCP|October 1, 2019
Interfacial anomaly in low global warming potential refrigerant blends as predicted by molecular dynamics simulationsYuting Li, Wael A Fouad, Lourdes F VegaJournal of Clinical Lipidology|December 19, 2021
Prevalence and significance of risk enhancing biomarkers in the United States population at intermediate risk for atherosclerotic diseaseGloria L Vega, Jijia Wang, Scott M GrundyPageof 2,254